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Abstract
In this study, we investigated the physiological regulation of energy metabo-
lism in wild-type (WT) and WFS1-deficient (Wfs1KO) mice by measuring the
effects of menthol treatment on the O2 consumption, CO2 production, rectal
body temperature, and heat production. The basal metabolism and behavior
was different between these genotypes as well as TRP family gene expressions.
Wfs1KO mice had a shorter life span and weighed less than WT mice. The
food and water intake of Wfs1KO mice was lower as well as the body temper-
ature when compared to their WT littermates. Furthermore, Wfs1KO mice
had higher basal O2 consumption, and CO2 and heat production than WT
mice. In addition, Wfs1KO mice showed a higher response to menthol admin-
istration in comparison to WT mice. The strongest menthol effect was seen
on different physiological measures 12 h after oral administration. The highest
metabolic response of Wfs1KO mice was seen at the menthol dose of 10 mg/
kg. Menthol increased O2 consumption, and CO2 and heat production in
Wfs1KO mice when compared to their WT littermates. In addition, the
expression of Trpm8 gene was increased. In conclusion, our results show that
the Wfs1KO mice develop a metabolic phenotype characterized with several
physiological dysfunctions.
Introduction
The first description of Wolfram syndrome (WS), an
autosomal recessive disorder, was reported in 1938. The
acronym DIDMOAD summarizes the most frequent find-
ings: diabetes insipidus, diabetes mellitus, optic atrophy,
and deafness. The minimal criteria for diagnosis are dia-
betes mellitus and optic atrophy (Strom et al. 1998).
The prevalence of children and adolescents aged
under 21 years with WS in Europe is 33/17,000,000
(~1:500,000), and the prevalence of children and adoles-
cents aged under 21 years with WS and diabetes is 33/
24,000 (~1:730) (Rohayem et al. 2011). The cause of WS is
the loss-of-function mutations in wolframin (Wfs1) gene
(Strom et al. 1998). Wfs1 is linked to the short arm of
chromosome 4 p16.1 (Polymeropoulos et al. 1994; Collier
et al. 1996). The Wfs1 gene encodes wolfamin (WFS1), a
protein with 890 amino acid residues and a molecular mass
of 100 kDa. WFS1 is a hydrophobic glycoprotein which
contains nine transmembrane segments, with the N-termi-
nus localized in the cytoplasma and the C-terminus in the
endoplasmic reticulum lumen (Hofmann et al. 2003).
WFS1 protein is expressed in the brain, heart, lungs, and
pancreatic b-cells (Inoue et al. 1998; Strom et al. 1998;
Hofmann et al. 2003; Ishihara et al. 2004). In the brain,
WFS1 is expressed in regions related to the neurological
disabilities. Prominent expression was evident in the hip-
pocampus, amygdala, olfactory tubercle, allocortex, ventral
striatum, prefrontal cortex, and proisocortical areas
(Takeda et al. 2001; Luuk et al. 2008). WFS1 expression
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sites suggest that WFS1 may function in emotional, behav-
ioral, and visceral control (Takeda et al. 2001).
Transient receptor potential melastatin 8 (TRPM8) and
transient receptor potential vanilloid 3 (TRPV3) are
members of the TRP ion channel family (McKemy et al.
2002). TRPM8 channels are activated by cold (8–28°C)
and chemicals, for example menthol, which induce cold
sensation, positive membrane potential, and activities of
endogenous signaling lipids like phosphatidylinositol-4,5-
bisphosphate (PIP2) (McKemy et al. 2002; Peier et al.
2002; Nilius et al. 2007). TRPV3 is being activated by
temperature >32–39°C or by chemical stimuli, for exam-
ple menthol (Xu et al. 2002; Macpherson et al. 2006).
McKemy et al. (2002) demonstrated that TRP ion chan-
nels are used as primary transducers of thermal stimuli
for thermosensation mediated by common molecular
mechanism. Analyzing our RNA sequencing results, we
found increased expression of Trpm8 and Trpv3 in the
hippocampus of Wfs1KO mice and therefore hypothe-
sized changed sensitivity in Wfs1KO mice to the meta-
bolic effects of menthol (Table S1).
The aim of this study was to compare the metabolic dif-
ferences and dose–response effects to menthol between
WFS1-deficient mice and their wild-type (WT) littermates.
Methods
Animals
WFS1-deficient (Wfs1KO) mice were generated by invali-
dating the eighth exon of the Wfs1 gene (Luuk et al.
2008). Experiments were performed with 9–12 months
old male F2 hybrids (129S6/SvEvTac x 129S6/SvEvTac).
Mice were kept in groups of eight per cage at 22  1°C
in a room illuminated artificially from 7 AM to 7 PM. Tap
water and food pellets were freely available. The permis-
sion (No. 71, 8 April 2011) for this study was given by
the Estonian National Board of Animal Experiments in
accordance with the European Communities Directive of
24th of November, 1986 (86/609/EEC). Metabolic experi-
ment was carried out with naive animals. Wfs1KO mice
were always used in parallel with their WT littermates
and the animals were randomly divided into experimental
groups.
Metabolic studies
Control group animals in the metabolic analysis received
an oral administration of water. L-menthol (W266523;
Sigma-Aldrich, St. Louis, MO, USA) was dissolved in
water on a heating plate at 40°C. L-menthol was stirred
before oral gavage administration of doses of 8, 10, 15,
and 20 mg/kg. Different doses were administrated in a
decreasing order on four consecutive days. L-menthol was
orally administered at a volume of 200 lL/30 g.
Eight Wfs1KO mice and eight WT mice were used in
the study with 8 mg/kg L-menthol. Twelve Wfs1KO and
twelve WT mice were used in the menthol study with 10,
15, and 20 mg/kg doses. There were five Wfs1KO mice
and eight WT mice in the control group. Mice were kept
1 week before metabolic measurement alone in cages. After
adaption period, the mice were studied in the metabolic
cages (TSE Phenomaster; TSE Systems GmbH, Bad Hom-
burg, Germany). Basal data were measured during the first
2 days in metabolic cages. The basal data of second day
were used in the analysis. Within the next 4 days, once per
day one of the following menthol dose 8, 10, 15, or 20 mg/
kg was given. Metabolic effect was measured 24 h after oral
menthol administration. For the next 4 days after 2 days
of basal data measurements, 0.2 mL of water was adminis-
trated by oral gavage to the control group once per day.
Rectal temperature (°C) was measured 1 and 2 h after oral
menthol administration. Food (g), water (mL), average O2
consumption (mL/h/kg), average CO2 production (mL/h/
kg), and average heat production (kcal/h/kg) data were
collected over time period of 24 h for each dose. Weight
change data were collected over time period of 4 days. The
metabolic data of mice were analyzed 3, 7, 12, and 14 h
after oral administration of menthol. Metabolic cages auto-
matically measured and software calculated energy con-
sumption H (kcal/kg/h), taking into account 100% the
weight of the mouse. The average respiratory coefficient
was calculated based on the average CO2 eliminated
divided with the average O2 consumed at certain time
point. Weight change was measured after 4 days of men-
thol administration to oral gavage.
Statistics
The results of the metabolic analysis are expressed as
mean values  SEM. Weight change, food consumption,
and drink consumption are expressed as mean val-
ues  SD. Mann–Whitney U-test was applied for the sta-
tistical analysis of metabolic data. For survival analysis,
we used Kaplan–Meyer estimator. P-value lower than 0.05
(P < 0.05) was considered statistically significant. Statisti-
cal analysis was done with statistical computing program
R software (http://www.r-project.org/).
Results
Life span
Wfs1KO mice have a shorter life span compared to WT
mice (P < 0.05) (Fig. 1). Average life span of Wfs1KO
was 11 months and that of WT mice 15–16 months.
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Body weight
The general physiological data are presented in the
Table 1. The body weights were statistically different
between genotypes. It was found that Wfs1KO mice
(WeightWfs1KO = 18.38  2.50 g) weigh less compared to
WT mice (WeightWT = 27.85  3.47 g) (Table 1).
Wfs1KO mice did not lose statistically more body weight
after menthol treatment compared to WT mice (Table 1).
Wfs1KO mice moderately remained or gained body
weight after menthol treatment (WeightWfs1KO =
0.22  2.44 g) compared to WT mice, which moderately
lost body weight after menthol treatment (WeightWT =
0.25  1.33 g).
Food and water consumption
The food and water intake in Wfs1KO mice
(FoodWfs1KO = 1.48  1.03 g, WaterWfs1KO = 1.76  2.21
mL) was significantly lower compared to WT mice
(FoodWT = 2.54  0.94 g, WaterWT = 2.59  1.58 mL)
(Table 1). After menthol treatment, Wfs1KO mice did
not consume less food or water compared to WT mice
(Fig. 1).
Body temperature
The body temperatures were significantly higher in WT
mice (36.86  1.25°C) compared to Wfs1KO mice
(35.76  2.24°C) (Table 1). Wfs1KO and WT mice
body temperature rose 1 and 2 h after menthol treat-
ment, but the effect was not statistically significant. WT
mice had statistically higher body temperature 1 and
2 h after menthol treatment compared to Wfs1KO
mice. Interestingly, the effect of menthol on rising body
temperature was absent 1 and 2 h after menthol treat-
ment (Fig. S1).
Oxygen consumption and carbon dioxide
production
Wfs1KO mice (DO2 = 7290  1816 mL/h/kg) had
significantly higher basal O2 consumption and basal CO2
production (DCO2 = 6827  2177 mL/h/kg) compared
to WT mice (DO2 = 5435  1108 mL/h/kg, DCO2 =
5516  1352 mL/h/kg) (Table 1). The analysis of average
O2 consumption and CO2 production after oral menthol
administration showed that the effect on Wfs1KO mice
was significantly highest 12 h after administration com-
pared to WT mice. The strongest effect on Wfs1KO mice
was with menthol dose 10 mg/kg (Fig. 2). Average O2
consumption rose significantly 3 and 7 h after menthol
treatment. Average CO2 production rose significantly 3
and 12 h after menthol treatment. Menthol treatment
increased the average O2 consumption (DO2 = 7875 
1816 mL/h/kg) and CO2 production (DCO2 = 7616 
2177 mL/h/kg) of Wfs1KO mice compared to WT mice,
whose O2 consumption (DO2 = 5329  1108 mL/h/kg)
and CO2 production (DCO2 = 4988  1352 mL/h/kg)
decreased.
Figure 1. Comparison of life span between mice of different genotypes. Wfs1KO mice have a shorter life span compared to WT mice.
NWfs1KO = 9, NWT = 8.
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Thermogenesis
Wfs1KO mice (H = 36.07  9.79 kcal/h/kg) had signifi-
cantly higher heat production compared to WT mice
(H = 27.47  5.78 kcal/h/kg) (Table 1). The average heat
production after oral menthol administration showed that
the effect on Wfs1KO mice was significantly highest 12 h
after administration compared to WT mice. The strongest
effect on Wfs1KO mice was with menthol dose 10 mg/kg
(Fig. 3). Average heat production rose significantly 3 and
7 h after menthol treatment. Fourteen hours after men-
thol treatment, the average heat production of Wfs1KO
mice was increased (H = 39.46  9.79 kcal/h/kg) whereas
that of WT mice was decreased (H = 26.52  5.78 kcal/
h/kg).
Discussion
RNA sequencing showed that Trpm8 and Trpv3 genes
were overexpressed in the hippocampus of Wfs1KO mice
compared to WT littermates (Table S1). Warming the
skin of TRPM8-deficient (Trpm8KO) mice induces
TRPM8 output, which indicates that the thermostat of
the skin temperature against cooling acts TRPM8 (Tajino
et al. 2011). The core temperature of Trpm8KO mice was
lower in a room cooled from 27°C to 10°C compared to
WT mice with a slightly increased core temperature. The
skin temperature decreased by the same room cooling in
both mice indicating that TRPM8-induced thermogenesis
in the core is not powerful enough to warm the skin
against cooling (Tajino et al. 2011). Trpm8KO mice have
only about 5% of all neurons that are cold sensitive and
Trpm8KO mice cannot sense differences between warm
(30°C) or cold (15°C) temperatures compared to WT
mice (Bautista et al. 2007).
Noormets et al. (2014) showed that Wfs1KO mice
weigh less and lose more weight in the end of metabolic
experiment compared to WT mice. Koks et al. (2009)
have showed the reduced body weight phenotype in
Wfs1KO mice. Wfs1KO mice were much smaller and they
had damaged glucose tolerance (Luuk et al. 2009). In this
study, the body weight of Wfs1KO mice were significantly
lower compared to WT mice. Ma et al. (2012) showed
that the body weight was not different between mice on
chow diet with and without menthol, although mice on
dietary menthol had elevated activity and body tempera-
ture. Ma et al. (2012) confirmed that menthol mainly
affected body fat, but not other compositions of body
weight. In this study, there was no statistical significance
to prove that Wfs1KO mice lost more body weight at the
end of the experiment compared to WT mice after being
treated orally with different doses of menthol.
It is important to investigate the changes in metabolism
caused by WS, since patients with WS have neurodegen-
erative characteristics (Strom et al. 1998). Studies have
shown that patients with Alzheimer’s, Parkinsons’s, or
Huntington’s diseases have impaired glucose metabolism,
increased insulin resistance and abnormal appetite regula-
tion (Cai et al. 2012). Patients with Huntington’s disease
show severe weight loss in spite of healthy appetite and
high caloric intake (Morales et al. 1989; Trejo et al. 2004;
Cai et al. 2012). Patients with Huntington’s disease also
have higher energy expenditure compared to controls
(Pratley et al. 2000; Stoy and McKay 2000; Gaba et al.
2005; Cai et al. 2012). Patients with Parkinson’s disease
have the same characteristics (Cai et al. 2012). Cai et al.
(2012) has suggested that there is a link between the pro-
gression of Huntington’s disease and Parkinson’s disease
and metabolic dysfunction. This study shows that
Table 1. Average data of basal and menthol treatment of differ-
ent metabolic parameters.
Wfs1KO WT
Weight (g) 18.38  2.50 27.85  3.47***
Weight change (Dg) 0.22  2.44 0.25  1.33
Food consumption (g) 1.48  1.03 2.54  0.94***
Food consumption (Dg) 0.2  0.34 0.24  0.58
Water consumption (mL) 1.76  2.21 2.59  1.58*
Water consumption
(DmL)
0.38  0.23 0.36  0.18
Body temperature (°C) 35.76  2.24 36.86  1.25*
Body temperature change
after 1 h menthol
administration (D°C)
0.57  2.24 0.65  1.25
Body temperature change
after 2 h menthol
administration (D°C)
0.68  2.24 0.77  1.25
O2 consumption
(mL/h/kg)
7290  1816*** 5435  1108
CO2 production (mL/h/kg) 6827  2177** 5516  1352
Heat production
(kcal/h/kg)
36.07  9.79*** 27.47  5.78
Respiratory coefficient
3 h after menthol
administration
0.89 0.89
Respiratory coefficient
7 h after menthol
administration
0.92 0.87
Respiratory coefficient
12 h after menthol
administration
0.96 0.92
Respiratory coefficient
14 h after menthol
administration
0.97 0.94
Data are expressed as mean values  SD.
*P < 0.05.
**P < 0.005.
***P < 0.001.
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Wfs1KO mice have a shorter life span compared to WT
mice. Restoring the metabolic homeostasis may improve
cognitive and motor function, and also increase life span
in patients with Alzheimer’s or Huntington’s disease
(Watson et al. 2005; Martin et al. 2009).
Ma et al. (2012) showed that long-term dietary men-
thol treatment had no effect on food intake in WT mice.
The results in this study showed that Wfs1KO mice con-
sume less food and water compared to WT mice. After
menthol treatment, Wfs1KO mice did not consume less
food or water compared to WT mice, which mean that
the statistical significance between genotypes after men-
thol treatment disappeared.
Ma et al. (2012) showed that dietary menthol signifi-
cantly increased oxygen consumption in WT mice, but
not in Trpm8KO mice, suggesting that dietary menthol
increased the resting metabolic rate through TRPM8 acti-
vation. Ma et al. (2012) results are in correspondence
with the results of this study since Wfs1KO mice have
overexpressed Trpm8, which might be the cause of higher
basal O2 consumption and CO2 production compared to
WT mice.
Kozyreva et al. (2013) results showed that 1% suspen-
sion of menthol in saline increased O2 consumption and
CO2 release less than 30% in response to warming. The res-
piratory coefficient did not change during warming. Under
thermoneutral conditions, menthol activation of TRPM8
reduced the respiratory coefficient by enhancing O2 con-
sumption by 10% at constant CO2 release (Kozyreva et al.
2013). In this study, menthol treatment increased the
average respiratory coefficient of Wfs1KO mice and
decreased the average respiratory coefficient of WT mice
Figure 2. Oxygen consumption and carbon dioxide production comparison in Wfs1KO and WT mice 12 h after oral menthol administration.
Wfs1KO mice oxygen consumption and carbon dioxide production is statistically higher after oral menthol administration of doses 8, 10, 15,
and 20 mg/kg compared to WT mice. Statistically, highest effect on oxygen consumption and carbon dioxide production had menthol dose
10 mg/kg. Wfs1KO – Wfs1-deficient mice, WT – wild-type mice, O2 – oxygen consumption (mL/h/kg), CO2 – carbon dioxide production (mL/h/
kg). N = 8–12 for each group. *P < 0.05, **P < 0.005, ***P < 0.001.
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and recovered 12 h after menthol treatment followed in
increasing. This study also showed that the difference in O2
consumption and CO2 production between genotypes was
biggest at 12 h after menthol administration and with men-
thol dose of 10 mg/kg. Kozyreva et al. (2013) results
showed that O2 consumption and CO2 production did not
differ after TRPM8 activation with menthol. In this study,
the strongest menthol effect was seen with the oral dose of
10 mg/kg resulting in increased O2 consumption and CO2
production of Wfs1KO mice. Furthermore, the overall
menthol treatment increased the average O2 consumption
and CO2 production in Wfs1KO mice compared to WT
mice showing an opposite response with the decreased
average O2 consumption and CO2 production.
In this study, Wfs1KO mice had significantly higher
basal heat production compared to WT mice. Noormets
et al. (2014) studies showed that the mean heat produc-
tion was not different between Wfs1KO and WT mice.
Mean oxygen consumption was higher in Wfs1KO female
mice compared to Wfs1KO male mice. No such differ-
ence was seen compared to the WT mice littermates nei-
ther between the sexes within the WT mice group
(Noormets et al. 2014). The differences between two
studies might be the age of the mice. Noormets et al.
(2014) used 2–3 months old mice, but in this study
9–12 months old mice were used. The change in heat
production of Wfs1KO mice was noticeable. In this study,
menthol dose of 10 mg/kg raised significantly Wfs1KO
mice heat production from the beginning of 3 h after oral
menthol administration. The strongest effect on Wfs1KO
heat production was at 10 mg/kg menthol dose 12 h after
oral administration. Different menthol doses had low
effect on WT mice or even lowered their heat production
compared to control group.
Masamoto et al. (2009) measurements showed that
administration of 20 mg/kg menthol increased both
Figure 3. Menthol activated heat production in Wfs1KO and WT mice. Wfs1KO heat production is statistically higher after oral menthol
administration of doses 8, 10, 15, and 20 mg/kg compared to WT mice. Statistically, highest effect on heat production had menthol dose
10 mg/kg. Wfs1KO – Wfs1-deficient mice, WT – wild-type mice, circle – mice heat production (kcal/h/kg) 3 h after oral menthol administration,
triangle – mice heat production (kcal/h/kg) 7 h after oral menthol administration, square – mice heat production (kcal/h/kg) 12 h after oral
menthol administration, cross – mice heat production (kcal/h/kg) 14 h after oral menthol administration. N = 8–12 for each group. *P < 0.05,
**P < 0.005, ***P < 0.001.
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colonic temperatures, by inserting the thermistor 2 cm
into the colon, and intrascapular brown adipose tissue
temperature, by the thermistor placed between an
intrascapular brown adipose tissue pad and the trapezius
muscle. The tail-skin temperature did not change after
the infusion with TRPM8 agonists menthol or 1,8-
cineole. In this study, the average body temperature of
Wfs1KO and WT mice increased 1 and 2 h after men-
thol treatment, but the results were not statistically sig-
nificant between genotypes. The lack of menthol effect
on body temperature change may be explained with
Masamoto et al. (2009) results, which suggest that men-
thol-induced thermogenesis did not have effect on heat
diffusion. Ma et al. (2012) showed that dietary menthol
markedly increased the locomotor activity and rectal
temperature of WT mice, but the effect was almost
absent in Trpm8KO mice. Measuring of 24 h ambulatory
core body temperature, they found that during the day
time, core temperatures were not different, but during
the nocturnal, core temperatures were significantly higher
in WT mice on the menthol diet compared with WT
mice on the chow diet compared to Trpm8KO mice,
whose core body temperature was not significantly higher
either during nocturnal and day time. In this study, only
the rectal body temperature was measured and the body
temperature changes had no statistical significance 1 and
2 h after oral administration with different menthol
doses, but WT mice have significantly higher body tem-
perature 1 and 2 h after menthol treatment compared to
Wfs1KO mice. Different menthol doses were orally
administrated during day time and it is possible that 2 h
after menthol administration the effect of menthol on
body temperature was not apparent yet.
Conclusions
Wfs1KO mice weigh less than WT mice indicating some
metabolic disturbances in the mutant mice. Wfs1KO mice
have also significantly higher O2 consumption, and CO2
and heat production compared to WT mice. The experi-
ments revealed that the dose of 10 mg/kg of a TRPM8
agonist, menthol, is most effective by increasing the heat
production, O2 consumption, and CO2 production of
Wfs1KO mice compared to WT mice. Interestingly, men-
thol increased the metabolic parameters of Wfs1KO mice
compared to WT mice, whose average metabolic parame-
ters decreased after menthol treatment. The shorter life
span, metabolic changes and overexpression of Trpm8
gene in Wfs1KO mice suggest that Wfs1KO mice have
serious metabolic dysfunctions. Further studies are in
progress to clarify the mechanism of menthol and the role
of Trpm8 gene in the metabolism of Wfs1KO and WT
mice.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Expression of TRP family genes in the hip-
pocampus of Wfs1KO mice. RNA sequencing results for
TRP family genes in the hippocampus of Wfs1KO mice
compared to WT mice showed upregulation of Trpm8
and Trpv3 genes as log ratio of fold change (logC) >2
and false discovery rate (FDR) <0.05 was considered sig-
nificant.
Figure S1. Effect of menthol treatment on body tempera-
ture in Wfs1KO and WT mice. Different menthol doses
did not change the body temperature of Wfs1KO mice
and WT mice after 1 and 2 h of oral administration.
Wfs1KO – body temperature (°C) of Wfs1-deficient mice,
WT – body temperature (°C) of wild-type mice. Circle –
mice rectal body temperature 1 h after menthol treat-
ment, triangle – mice mice rectal body temperature 2 h
after menthol treatment. *P < 0.05, **P < 0.005,
***P < 0.001.
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